{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:48:36Z","timestamp":1794955716833,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970782"],"award-info":[{"award-number":["81970782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670829"],"award-info":[{"award-number":["81670829"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study was set out to address the therapeutic efficacy of human adipose tissue stem cells derived extracellular vesicles (hADSC-Evs) in a mouse model of dry eye disease and to investigate the underlying mechanisms involved. hADSC-Evs eye drops were topically administered to mice that subjected to desiccating stress (DS). Clinical parameters of ocular surface damage were assessed with fluorescein staining, tear production and PAS staining. For in vitro studies, cell viability assay and TUNEL staining were performed in human corneal epithelial cells (HCECs) treated with hADSC-Evs under hyperosmotic media. In addition, immunofluorescent staining, Real-time PCR (qRT-PCR) and Western blots were used to evaluated NLRP3, ASC, caspase-1, and IL-1\u03b2 expression levels. Compared with vehicle control mice, topical hADSC-Evs treated mice showed decreased corneal epithelial defects, increased tear production, decreased goblet cell loss, as well as reduced inflammatory cytokines production. In vitro, hADSC-Evs could protect HCECs against hyperosmotic stress-induced cell apoptosis. Mechanistically, hADSC-Evs treatment suppressed the DS induced rises in NLRP3 inflammasome formation, caspase-1 activation and IL-1\u03b2 maturation. In conclusion, hADSC-Evs eye drops effectively suppress NLRP3 inflammatory response and alleviate ocular surface damage in dry eye disease.<\/jats:p>","DOI":"10.1038\/s41598-020-71337-8","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T10:04:10Z","timestamp":1599127450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye"],"prefix":"10.1038","volume":"10","author":[{"given":"Chaoqun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohu","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"71337_CR1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder, S. C. & de Paiva, C. S. The pathophysiology of dry eye disease: What we know and future directions for research. Ophthalmology 124, S4\u2013S13. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.010 (2017).","journal-title":"Ophthalmology"},{"key":"71337_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","volume":"182","author":"KF Farrand","year":"2017","unstructured":"Farrand, K. F., Fridman, M., Stillman, I. O. & Schaumberg, D. A. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am. J. Ophthalmol. 182, 90\u201398. https:\/\/doi.org\/10.1016\/j.ajo.2017.06.033 (2017).","journal-title":"Am. J. Ophthalmol."},{"key":"71337_CR3","doi-asserted-by":"publisher","first-page":"748654","DOI":"10.1155\/2014\/748654","volume":"2014","author":"NN Liu","year":"2014","unstructured":"Liu, N. N., Liu, L., Li, J. & Sun, Y. Z. Prevalence of and risk factors for dry eye symptom in mainland china: A systematic review and meta-analysis. J. Ophthalmol. 2014, 748654. https:\/\/doi.org\/10.1155\/2014\/748654 (2014).","journal-title":"J. Ophthalmol."},{"key":"71337_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig, J. P. et al. TFOS DEWS II definition and classification report. Ocular Surf. 15, 276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008 (2017).","journal-title":"Ocular Surf."},{"key":"71337_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron, A. J. et al. TFOS DEWS II pathophysiology report. Ocular Surf. 15, 438\u2013510. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.011 (2017).","journal-title":"Ocular Surf."},{"key":"71337_CR6","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.ophtha.2017.08.029","volume":"124","author":"MK Rhee","year":"2017","unstructured":"Rhee, M. K. & Mah, F. S. Inflammation in dry eye disease: How do we break the cycle?. Ophthalmology 124, S14\u2013S19. https:\/\/doi.org\/10.1016\/j.ophtha.2017.08.029 (2017).","journal-title":"Ophthalmology"},{"key":"71337_CR7","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.ophtha.2017.07.022","volume":"124","author":"P Thulasi","year":"2017","unstructured":"Thulasi, P. & Djalilian, A. R. Update in current diagnostics and therapeutics of dry eye disease. Ophthalmology 124, S27\u2013S33. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.022 (2017).","journal-title":"Ophthalmology"},{"key":"71337_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143\u2013147. https:\/\/doi.org\/10.1126\/science.284.5411.143 (1999).","journal-title":"Science"},{"key":"71337_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/mt.2014.159","volume":"23","author":"MJ Lee","year":"2015","unstructured":"Lee, M. J. et al. Mesenchymal stem\/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye. Mol. Therapy 23, 139\u2013146. https:\/\/doi.org\/10.1038\/mt.2014.159 (2015).","journal-title":"Mol. Therapy"},{"key":"71337_CR10","doi-asserted-by":"publisher","first-page":"250230","DOI":"10.1155\/2014\/250230","volume":"2014","author":"E Beyazyildiz","year":"2014","unstructured":"Beyazyildiz, E. et al. Efficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome model. Stem Cells Int. 2014, 250230. https:\/\/doi.org\/10.1155\/2014\/250230 (2014).","journal-title":"Stem Cells Int."},{"key":"71337_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau, J. & Sensebe, L. Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities. Cell Stem Cell 22, 824\u2013833. https:\/\/doi.org\/10.1016\/j.stem.2018.05.004 (2018).","journal-title":"Cell Stem Cell"},{"key":"71337_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","volume":"2","author":"G Ren","year":"2008","unstructured":"Ren, G. et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2, 141\u2013150. https:\/\/doi.org\/10.1016\/j.stem.2007.11.014 (2008).","journal-title":"Cell Stem Cell"},{"key":"71337_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13287-019-1372-0","volume":"10","author":"N Li","year":"2019","unstructured":"Li, N. et al. Recent advances of exosomes in immune-mediated eye diseases. Stem Cell Res. Therapy 10, 278. https:\/\/doi.org\/10.1186\/s13287-019-1372-0 (2019).","journal-title":"Stem Cell Res. Therapy"},{"key":"71337_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney, D. G. & Pittenger, M. F. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells 35, 851\u2013858. https:\/\/doi.org\/10.1002\/stem.2575 (2017).","journal-title":"Stem Cells"},{"key":"71337_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13287-018-0791-7","volume":"9","author":"S Keshtkar","year":"2018","unstructured":"Keshtkar, S., Azarpira, N. & Ghahremani, M. H. Mesenchymal stem cell-derived extracellular vesicles: Novel frontiers in regenerative medicine. Stem Cell Res. Therapy 9, 63. https:\/\/doi.org\/10.1186\/s13287-018-0791-7 (2018).","journal-title":"Stem Cell Res. Therapy"},{"key":"71337_CR16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/mt.2015.44","volume":"23","author":"S Rani","year":"2015","unstructured":"Rani, S., Ryan, A. E., Griffin, M. D. & Ritter, T. Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol. Therapy 23, 812\u2013823. https:\/\/doi.org\/10.1038\/mt.2015.44 (2015).","journal-title":"Mol. Therapy"},{"key":"71337_CR17","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1167\/iovs.18-25310","volume":"59","author":"B Mead","year":"2018","unstructured":"Mead, B., Ahmed, Z. & Tomarev, S. Mesenchymal stem cell-derived small extracellular vesicles promote neuroprotection in a genetic DBA\/2J mouse model of glaucoma. Investig. Ophthalmol. Vis. Sci. 59, 5473\u20135480. https:\/\/doi.org\/10.1167\/iovs.18-25310 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR18","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","volume":"8","author":"T Shigemoto-Kuroda","year":"2017","unstructured":"Shigemoto-Kuroda, T. et al. MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: Type 1 diabetes and uveoretinitis. Stem Cell Rep. 8, 1214\u20131225. https:\/\/doi.org\/10.1016\/j.stemcr.2017.04.008 (2017).","journal-title":"Stem Cell Rep."},{"key":"71337_CR19","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1167\/iovs.18-24803","volume":"59","author":"R Samaeekia","year":"2018","unstructured":"Samaeekia, R. et al. Effect of human corneal mesenchymal stromal cell-derived exosomes on corneal epithelial wound healing. Investig. Ophthalmol. Vis. Sci. 59, 5194\u20135200. https:\/\/doi.org\/10.1167\/iovs.18-24803 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13287-019-1358-y","volume":"10","author":"P Hong","year":"2019","unstructured":"Hong, P., Yang, H., Wu, Y., Li, K. & Tang, Z. The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: A comprehensive review. Stem Cell Res. Therapy 10, 242. https:\/\/doi.org\/10.1186\/s13287-019-1358-y (2019).","journal-title":"Stem Cell Res. Therapy"},{"key":"71337_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2337\/db17-0356","volume":"67","author":"H Zhao","year":"2018","unstructured":"Zhao, H. et al. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes 67, 235\u2013247. https:\/\/doi.org\/10.2337\/db17-0356 (2018).","journal-title":"Diabetes"},{"key":"71337_CR22","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1167\/iovs.19-26928","volume":"60","author":"M Qu","year":"2019","unstructured":"Qu, M. et al. Therapeutic effects of STAT3 inhibition on experimental murine dry eye. Investig. Ophthalmol. Vis. Sci. 60, 3776\u20133785. https:\/\/doi.org\/10.1167\/iovs.19-26928 (2019).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR23","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1167\/iovs.17-22240","volume":"58","author":"Y Wu","year":"2017","unstructured":"Wu, Y. et al. Therapeutic effect of MK2 inhibitor on experimental murine dry eye. Investig. Ophthalmol. Vis. Sci. 58, 4898\u20134907. https:\/\/doi.org\/10.1167\/iovs.17-22240 (2017).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR24","doi-asserted-by":"publisher","first-page":"29827","DOI":"10.1074\/jbc.M114.597161","volume":"289","author":"L Wang","year":"2014","unstructured":"Wang, L., Dai, W. & Lu, L. Osmotic stress-induced phosphorylation of H2AX by polo-like kinase 3 affects cell cycle progression in human corneal epithelial cells. J. Biol. Chem. 289, 29827\u201329835. https:\/\/doi.org\/10.1074\/jbc.M114.597161 (2014).","journal-title":"J. Biol. Chem."},{"key":"71337_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jaut.2017.02.006","volume":"80","author":"W Chi","year":"2017","unstructured":"Chi, W. et al. Mitochondrial DNA oxidation induces imbalanced activity of NLRP3\/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. J. Autoimmunity 80, 65\u201376. https:\/\/doi.org\/10.1016\/j.jaut.2017.02.006 (2017).","journal-title":"J. Autoimmunity"},{"key":"71337_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2014.05.001","volume":"125","author":"Q Zheng","year":"2014","unstructured":"Zheng, Q. et al. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye. Exp. Eye Res. 125, 1\u20138. https:\/\/doi.org\/10.1016\/j.exer.2014.05.001 (2014).","journal-title":"Exp. Eye Res."},{"key":"71337_CR27","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/mt.2012.208","volume":"20","author":"J Weng","year":"2012","unstructured":"Weng, J. et al. Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease. Mol. Therapy 20, 2347\u20132354. https:\/\/doi.org\/10.1038\/mt.2012.208 (2012).","journal-title":"Mol. Therapy"},{"key":"71337_CR28","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu, J. et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjogren syndrome. Blood 120, 3142\u20133151. https:\/\/doi.org\/10.1182\/blood-2011-11-391144 (2012).","journal-title":"Blood"},{"key":"71337_CR29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13287-019-1398-3","volume":"10","author":"KS Park","year":"2019","unstructured":"Park, K. S., Bandeira, E., Shelke, G. V., Lasser, C. & Lotvall, J. Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res. Therapy 10, 288. https:\/\/doi.org\/10.1186\/s13287-019-1398-3 (2019).","journal-title":"Stem Cell Res. Therapy"},{"key":"71337_CR30","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1167\/iovs.18-24935","volume":"60","author":"H Lee","year":"2019","unstructured":"Lee, H., Jeon, S., Kim, C. E., Park, Y. J. & Yang, J. A new ophthalmic pharmaceutical formulation, topical sulglycotide, enhances the ocular mucin secretion in desiccation stress-mediated dry eye disease. Investig. Ophthalmol. Vis. Sci. 60, 1076\u20131087. https:\/\/doi.org\/10.1167\/iovs.18-24935 (2019).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1167\/iovs.17-23651","volume":"59","author":"T Yamaguchi","year":"2018","unstructured":"Yamaguchi, T. Inflammatory response in dry eye. Investig. Ophthalmol. Vis. Sci. 59, 192\u2013199. https:\/\/doi.org\/10.1167\/iovs.17-23651 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov. 17, 588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71337_CR33","doi-asserted-by":"publisher","first-page":"101093","DOI":"10.1016\/j.redox.2018.101093","volume":"21","author":"Y Dai","year":"2018","unstructured":"Dai, Y. et al. Calcitriol inhibits ROS-NLRP3-IL-1beta signaling axis via activation of Nrf2-antioxidant signaling in hyperosmotic stress stimulated human corneal epithelial cells. Redox Biol. 21, 101093. https:\/\/doi.org\/10.1016\/j.redox.2018.101093 (2018).","journal-title":"Redox Biol."},{"key":"71337_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.exer.2015.02.013","volume":"134","author":"Q Zheng","year":"2015","unstructured":"Zheng, Q. et al. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients. Exp. Eye Res. 134, 133\u2013140. https:\/\/doi.org\/10.1016\/j.exer.2015.02.013 (2015).","journal-title":"Exp. Eye Res."},{"key":"71337_CR35","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","volume":"508","author":"L Jiang","year":"2019","unstructured":"Jiang, L. et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages. Biochem. Biophys. Res. Commun. 508, 735\u2013741. https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.189 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"71337_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1096\/fj.201700602R","volume":"J32","author":"B Zhang","year":"2018","unstructured":"Zhang, B. et al. Silybin inhibits NLRP3 inflammasome assembly through the NAD(+)\/SIRT2 pathway in mice with nonalcoholic fatty liver disease. FASEB J32, 757\u2013767. https:\/\/doi.org\/10.1096\/fj.201700602R (2018).","journal-title":"FASEB"},{"key":"71337_CR37","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.5966\/sctm.2015-0239","volume":"5","author":"GY Liu","year":"2016","unstructured":"Liu, G. Y. et al. Adipose-derived mesenchymal stem cells ameliorate lipid metabolic disturbance in mice. Stem Cells Transl. Med. 5, 1162\u20131170. https:\/\/doi.org\/10.5966\/sctm.2015-0239 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"71337_CR38","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1038\/s41598-018-24506-9","volume":"8","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Netrin-1 promotes diabetic corneal wound healing through molecular mechanisms mediated via the adenosine 2B receptor. Sci. Rep. 8, 5994. https:\/\/doi.org\/10.1038\/s41598-018-24506-9 (2018).","journal-title":"Sci. Rep."},{"key":"71337_CR39","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.22958","volume":"8","author":"CY Chen","year":"2018","unstructured":"Chen, C. Y. et al. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics 8, 1607\u20131623. https:\/\/doi.org\/10.7150\/thno.22958 (2018).","journal-title":"Theranostics"},{"key":"71337_CR40","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1167\/iovs.18-24013","volume":"59","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. 0.005% Preservative-free latanoprost induces dry eye-like ocular surface damage via promotion of inflammation in mice. Investig. Ophthalmol. Vis. Sci. 59, 3375\u20133384. https:\/\/doi.org\/10.1167\/iovs.18-24013 (2018).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR41","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1167\/iovs.16-21372","volume":"58","author":"G Di","year":"2017","unstructured":"Di, G. et al. Corneal epithelium-derived neurotrophic factors promote nerve regeneration. Investig. Ophthalmol. Vis. Sci. 58, 4695\u20134702. https:\/\/doi.org\/10.1167\/iovs.16-21372 (2017).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR42","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1167\/iovs.17-21506","volume":"58","author":"G Di","year":"2017","unstructured":"Di, G. et al. Mesenchymal stem cells promote diabetic corneal epithelial wound healing through TSG-6-dependent stem cell activation and macrophage switch. Investig. Ophthalmol. Vis. Sci. 58, 4344\u20134354. https:\/\/doi.org\/10.1167\/iovs.17-21506 (2017).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"71337_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbrc.2019.09.020","volume":"519","author":"C Yu","year":"2019","unstructured":"Yu, C., Chen, H., Qi, X., Chen, P. & Di, G. Annexin A1 mimetic peptide Ac2-26 attenuates mechanical injury induced corneal scarring and inflammation. Biochem. Biophys. Res. Commun. 519, 396\u2013401. https:\/\/doi.org\/10.1016\/j.bbrc.2019.09.020 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"71337_CR44","doi-asserted-by":"publisher","first-page":"40582","DOI":"10.1038\/srep40582","volume":"7","author":"G Di","year":"2017","unstructured":"Di, G. et al. VEGF-B promotes recovery of corneal innervations and trophic functions in diabetic mice. Sci. Rep. 7, 40582. https:\/\/doi.org\/10.1038\/srep40582 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71337-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71337-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71337-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T17:42:28Z","timestamp":1670348548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71337-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71337"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71337-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14521"}}